Five things to know:
1. The percentage of outpatient visits for influenza-like illness increased to 5.1 percent for the week ending Feb. 16, which is above the national baseline of 2.2 percent. All 10 regions reported influenza-like illness at or above their region-specific baseline level.
2. The percentage of respiratory specimens testing positive for influenza viruses in clinical laboratories increased. Influenza A (H1N1) viruses predominated in most areas of the country, but influenza A(H3) viruses predominated in the southeastern U.S.
3. The CDC reported 7,922 laboratory-confirmed flu-associated hospitalizations from Oct. 1, 2018, through Feb. 16. The overall flu-associated hospitalization rate was 27.4 per 100,000 population.
4. Thirty states experienced high influenza-like illness activity for the week ending Feb. 16. Eleven states experienced moderate activity; six states experienced low activity; and three states experienced minimal activity.
5. Forty-eight states reported widespread flu activity for the week ending Feb. 16. West Virginia reported regional activity, and Hawaii reported sporadic activity.
More articles on clinical leadership and infection control:
FDA chief: Feds may act if states don’t change vaccine exemption laws
Flu season may contribute to kidney failure deaths, study finds
Race, other socioeconomic factors linked to community-acquired MRSA risk
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
